Your browser doesn't support javascript.
loading
Undetectable circulating tumor DNA (ctDNA) levels correlate with favorable outcome in metastatic melanoma patients treated with anti-PD1 therapy.
Seremet, Teofila; Jansen, Yanina; Planken, Simon; Njimi, Hassan; Delaunoy, Mélanie; El Housni, Hakim; Awada, Gil; Schwarze, Julia Katharina; Keyaerts, Marleen; Everaert, Hendrik; Lienard, Danielle; Del Marmol, Véronique; Heimann, Pierre; Neyns, Bart.
Afiliação
  • Seremet T; Department of Medical Oncology, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel (VUB), Laarbeeklaan 101, 1090, Brussels, Belgium. teofila.caplanusi@uzbrussel.be.
  • Jansen Y; Department of Dermatology, Hôpital Erasme, Université Libre de Bruxelles (ULB), Brussels, Belgium. teofila.caplanusi@uzbrussel.be.
  • Planken S; Department of Medical Oncology, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel (VUB), Laarbeeklaan 101, 1090, Brussels, Belgium.
  • Njimi H; Department of Medical Oncology, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel (VUB), Laarbeeklaan 101, 1090, Brussels, Belgium.
  • Delaunoy M; Department of Biomedical Statistics, Université Libre de Bruxelles (ULB), Brussels, Belgium.
  • El Housni H; Laboratory of Molecular Biology in Haemato-oncology, LHUB-ULB, Hôpital Erasme, Université Libre de Bruxelles (ULB), Brussels, Belgium.
  • Awada G; Laboratory of Molecular Biology in Haemato-oncology, LHUB-ULB, Hôpital Erasme, Université Libre de Bruxelles (ULB), Brussels, Belgium.
  • Schwarze JK; Department of Medical Oncology, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel (VUB), Laarbeeklaan 101, 1090, Brussels, Belgium.
  • Keyaerts M; Department of Medical Oncology, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel (VUB), Laarbeeklaan 101, 1090, Brussels, Belgium.
  • Everaert H; Department of Nuclear Medicine, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel (VUB), Brussels, Belgium.
  • Lienard D; Department of Nuclear Medicine, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel (VUB), Brussels, Belgium.
  • Del Marmol V; Department of Dermatology, Hôpital Erasme, Université Libre de Bruxelles (ULB), Brussels, Belgium.
  • Heimann P; Department of Dermatology, Hôpital Erasme, Université Libre de Bruxelles (ULB), Brussels, Belgium.
  • Neyns B; Laboratory of Molecular Biology in Haemato-oncology, LHUB-ULB, Hôpital Erasme, Université Libre de Bruxelles (ULB), Brussels, Belgium.
J Transl Med ; 17(1): 303, 2019 09 05.
Article em En | MEDLINE | ID: mdl-31488153
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptor de Morte Celular Programada 1 / DNA Tumoral Circulante / Melanoma Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptor de Morte Celular Programada 1 / DNA Tumoral Circulante / Melanoma Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article